Nutricia North America

This Week in Health News: 11 Stories You Need to See

Retrieved on: 
Friday, March 10, 2023

NEW YORK, March 10, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • The groundbreaking event, which takes place March 11 and March 12, will examine the science and storytelling around women's whole health.
  • Attendees will hear from experts and thought leaders, including Katie Couric, Maria Shriver, Christy Turlington Burns, Dr. Laurie Santos, Phoebe Robinson, Judy Greer, Dr. Piraye Yurttas Beim, Emma Lovewell, Jessi Miley-Dyer, and Jamie Wheal.
  • Health App Uses ChatGPT to Replace Human Health Coaches The AI coach provides instant answers to user questions, offers guidance and motivation, and helps them achieve their weight goals.
  • It can be customized to meet individual needs, allowing users to tailor their experience to their unique situation.

Danone Announces New Hypoallergenic Baby Formula Brand Pepticate, Now Available in the U.S.

Retrieved on: 
Monday, March 6, 2023

WHITE PLAINS, N.Y. and BROOMFIELD, Colo., March 6, 2023 /PRNewswire/ -- Danone North America, today announced alongside its Specialized Nutrition business, Nutricia, the availability of Pepticate in the U.S. to help support families with food allergies as the country continues to face a formula shortage.

Key Points: 
  • Sold in Europe for more than 30 years, Pepticate is Europe's #1 hypoallergenic extensively hydrolyzed baby formula for cow milk allergy.
  • *
    Danone's introduction of Pepticate to the U.S. builds on the company's existing efforts to alleviate the national formula shortage.
  • That's very important for families, since a good tasting formula may decrease the likelihood of formula refusal and repeated doctor visits."
  • The introduction of Pepticate to the U.S. is one of several steps Danone has taken to help American families navigate the baby formula shortage.

Collagen Matrix, Inc., appoints Wendell Raddatz as Vice President of Strategic Alliances

Retrieved on: 
Tuesday, May 3, 2022

OAKLAND, N.J., May 3, 2022 /PRNewswire/ -- Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen- and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Wendell Raddatz as Vice President, Strategic Alliances.

Key Points: 
  • OAKLAND, N.J., May 3, 2022 /PRNewswire/ -- Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen- and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Wendell Raddatz as Vice President, Strategic Alliances.
  • Wendell joins Collagen Matrix after an extensive career in sales and business development with leading manufacturers of healthcare and consumer products.
  • Prior to joining Collagen Matrix, he served as Global Vice President of Sales for Metrex, a division of Envista Holdings.
  • Wendell will work closely with Collagen Matrix customers to create new opportunities to advance a shared pursuit of meaningful innovation.

Global EPA & DHA Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 3, 2021

The healthy aging-related benefits of DHA have also led to their successful utilization in geriatric nutrition products.

Key Points: 
  • The healthy aging-related benefits of DHA have also led to their successful utilization in geriatric nutrition products.
  • Furthermore, an increasing number of product launches across the world is favoring the industry growth.
  • The North America EPA and DHA ingredients market is primarily driven by innovations, both, in products and technologies.
  • It also facilitates the manufacturers to customize the combinations of EPA and DHA for their application in pharmaceutical and dietary supplements.

Fortini™ Infant Formula Clears FDA Review; Energy- and Nutrient-dense Formula Aims to Set New Standard in U.S. to Support Growth in Infants with, or at Risk of, Failure to Thrive

Retrieved on: 
Thursday, September 23, 2021

It is the first and only 30 kcal/fl oz formula in the U.S. that is nutritionally complete, ready-to-feed and specifically calibrated for term infants with undernutrition or failure to thrive.

Key Points: 
  • It is the first and only 30 kcal/fl oz formula in the U.S. that is nutritionally complete, ready-to-feed and specifically calibrated for term infants with undernutrition or failure to thrive.
  • All formulas marketed in the United States must meet federal nutritional, growth and safety requirements, and infant formula manufacturers must notify the FDA prior to marketing a new formula.
  • Fortini has been shown in clinical trials to be well tolerated and supports weight gain and catch-up growth in failure-to-thrive infants under medical supervision.
  • Until now, there has been no such formula available in the U.S. for term infants with failure to thrive or growth failure.